Moore K - Search Results

1

T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.

Kaufman ME, Vayani OR, Moore K, Chlenski A, Wu T, Chavez G, Lee SM, Desai AV, He C, Cohn SL, Applebaum MA. Kaufman ME, et al. Among authors: moore k. bioRxiv [Preprint]. 2023 Jun 28:2023.06.26.546541. doi: 10.1101/2023.06.26.546541. bioRxiv. 2023. PMID: 37425883 Free PMC article. Preprint.

2

5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma.

Chennakesavalu M, Moore K, Chaves G, Veeravalli S, TerHaar R, Wu T, Lyu R, Chlenski A, He C, Piunti A, Applebaum MA. Chennakesavalu M, et al. Among authors: moore k. bioRxiv [Preprint]. 2023 Apr 30:2023.04.27.538309. doi: 10.1101/2023.04.27.538309. bioRxiv. 2023. PMID: 37163024 Free PMC article. Updated. Preprint.

3

Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.

Vayani OR, Kaufman ME, Moore K, Chennakesavalu M, TerHaar R, Chaves G, Chlenski A, He C, Cohn SL, Applebaum MA. Vayani OR, et al. Among authors: moore k. bioRxiv [Preprint]. 2023 Sep 1:2023.08.30.554943. doi: 10.1101/2023.08.30.554943. bioRxiv. 2023. PMID: 37693610 Free PMC article. Updated. Preprint.

4

5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma.

Chennakesavalu M, Moore K, Chaves G, Veeravalli S, TerHaar R, Wu T, Lyu R, Chlenski A, He C, Piunti A, Applebaum MA. Chennakesavalu M, et al. Among authors: moore k. JCO Precis Oncol. 2024 Jan;8:e2300297. doi: 10.1200/PO.23.00297. JCO Precis Oncol. 2024. PMID: 38295320

5

Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.

Pomaville M, Chennakesavalu M, Wang P, Jiang Z, Sun HL, Ren P, Borchert R, Gupta V, Ye C, Ge R, Zhu Z, Brodnik M, Zhong Y, Moore K, Salwen H, George RE, Krajewska M, Chlenski A, Applebaum MA, He C, Cohn SL. Pomaville M, et al. Among authors: moore k. Cell Rep. 2024 Apr 30;43(5):114165. doi: 10.1016/j.celrep.2024.114165. Online ahead of print. Cell Rep. 2024. PMID: 38691450 Free article.

6

Coaches Activating, Reaching, and Engaging Patients to Engage in Advance Care Planning: A Randomized Clinical Trial.

Rodriguez GM, Parikh DA, Kapphahn K, Gupta DM, Fan AC, Shah S, Srinivas S, Teuteberg W, Seevaratnam B, Asuncion K, Chien J, Moore K, Ruiz SM, Patel MI. Rodriguez GM, et al. Among authors: moore k. JAMA Oncol. 2024 May 23. doi: 10.1001/jamaoncol.2024.1242. Online ahead of print. JAMA Oncol. 2024. PMID: 38780960

7

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL, DiSilvestro PA, Mathews CA, Mutch DG, Hernandez ML, Martin LP, Bishop E, Gill SE, Gordinier ME, Burger RA, Aghajanian C, Liu JF, Moore KN, Bookman MA. Landen CN, et al. Among authors: moore kn. J Clin Oncol. 2024 May 22:JCO2302076. doi: 10.1200/JCO.23.02076. Online ahead of print. J Clin Oncol. 2024. PMID: 38776484

8

Investigating neuroepigenetic alterations in chronic low back pain with positron emission tomography.

Yoo CH, Rani N, Shen S, Loggia ML, Gaynor K, Moore KE, Bagdasarian FA, Lin YS, Edwards RR, Price JC, Hooker JM, Wey HY. Yoo CH, et al. Among authors: moore ke. Pain. 2024 May 21. doi: 10.1097/j.pain.0000000000003272. Online ahead of print. Pain. 2024. PMID: 38776171

9

Quantification of mechanical behavior of rat tail under compression.

Moore KD, Wu JZ, Krajnak K, Warren C, Dong RG. Moore KD, et al. Biomed Mater Eng. 2024 May 16. doi: 10.3233/BME-230170. Online ahead of print. Biomed Mater Eng. 2024. PMID: 38758990

10

Initiative to Increase Equity in Clinical Care: Experience at 1 Children's Hospital.

Payne AS, Moore K, Casazza A, Parikh K, Cora-Bramble D. Payne AS, et al. Among authors: moore k. Pediatrics. 2024 May 15:e2023063096. doi: 10.1542/peds.2023-063096. Online ahead of print. Pediatrics. 2024. PMID: 38747040 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,740 results

Search Page